|
Liposomal Concentrates
Liposomes
are small membrane microspheres consisting
of one or two layers of phospholipids (lecithin) and containing water in
their interior. A
spherical structure of
liposomes
allows to add them to the composition of water and fat-soluble biologically
active compounds Liposome
products 'UltraLipol'
series (on volunteers) have shown that
in comparison with traditional cosmetics liposomes demonstrated advantages
as follows:
1. More effective Carrier
of bioactive substances.
Liposomes
"deliver" vitamin E in large quantities to deeper layers of the
skin. 2. More effective Moisturizing
action.
Liposomes ensure
a great absorption of atmospheric water by skin and deliver moisturizing
substances directly to the most problematic areas. 3. More effective Anti-wrinkles
action. A comparable effectiveness of actions
of liposome and
traditional creams on wrinkles depth was studied It has been seen that the use of
liposome cosmetics
had more pronounced anti-wrinkles action, especially during first 10 days.
|
Liposome
ingredients 'UltraLipol' |
'UltraLipol'
is an aqueous dispersion of liposomes of submicronic sizes of natural lipids
of animal and vegetal origin ( lipids of yolk, soybean etc.) with biologically
active substances ( vitamins, amino acids, vegetal extracts etc.) Anti-aging
skincare, beauty and cosmetic products made with 'UltraLipol'
ingredients prevent aging and skin fading, smooth small wrinkles
and have top activity in penetrating through skin layers up to subcutis
|
All
cream-gels that include liposome
ingredient
'UltraLipol' as an active
component have hygienic certificates and conformity certificates.
Health and Medical
products based on 'UltraLipol'.
|
The elaboration
and production of highly effective liposome health and medical preparations
is possible on the base of liposome dispersions of the 'UltraLipol'
type.
Liposome
health and medical preparations for external use are considerably
more effective than traditional ones. Therefore, to obtain an equal
effect they need lesser concentration of biologically active components
in end drug form.
|
|
|